Hudson Bay Capital Management LP Edgewise Therapeutics, Inc. Transaction History
Hudson Bay Capital Management LP
- $21.9 Billion
- Q3 2024
A detailed history of Hudson Bay Capital Management LP transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 39,937 shares of EWTX stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,937Holding current value
$1.13 Million% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding EWTX
# of Institutions
191Shares Held
100MCall Options Held
2.17MPut Options Held
410K-
Orbimed Advisors LLC San Diego, CA15MShares$424 Million9.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$251 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$170 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$165 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$157 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.78B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...